Genitourinary tumours
Invited discussant abstracts 238O and 239O
Date
19 Dec 2015Session
Genitourinary tumoursPresenters
Winald GerritsenAuthors
W.R. GerritsenAuthor affiliations
- Department Of Medical Oncology, Radboud University Medical Centre Nijmegen, 6500 HB - Nijmegen/NL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
View the abstracts discussed:
Resources from the same session
1198 - A randomized phase III study comparing neoadjuvant chemotherapy followed by concurrent chemo-radiotherapy with concurrent chemo-radiotherapy in Asian-Indian (South Asian) population with muscle invasive bladder cancer
Presenter: Shankar Jakhar
Session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
448 - Adjuvant chemotherapy in patients with muscle invasive bladder cancer after radical cystectomy: now or never?
Presenter: Mai Ezz El Din
Session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
356 - Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma
Presenter: Mian Xie
Session: Genitourinary tumours
Resources:
Abstract
972 - RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
Presenter: Lin Yang
Session: Genitourinary tumours
Resources:
Abstract
897 - The prognostic significance of neutrophil to lymphocyte ratio and platelet count in patients with metastatic urothelial carcinoma
Presenter: Yu Li Su
Session: Genitourinary tumours
Resources:
Abstract
1292 - Treatment of locally recurrent prostate cancer following external beam radiotherapy or brachytherapy: In situ gene therapy with iodine-131 and the sodium iodide symporter gene
Presenter: Brian Davis
Session: Genitourinary tumours
Resources:
Abstract
492 - Subgroup analysis of Asian men in the PREVAIL trial of enzalutamide (ENZA) in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Edmund Chiong
Session: Genitourinary tumours
Resources:
Abstract
803 - Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
Presenter: Yinghao Sun
Session: Genitourinary tumours
Resources:
Abstract
Invited discussant abstracts 236O and 237O
Presenter: Joaquim Bellmunt
Session: Genitourinary tumours
Resources:
Slides
Webcast
Invited discussant abstracts 240PD, 241PD, 242PD and 243PD
Presenter: Oliver Sartor
Session: Genitourinary tumours
Resources:
Slides
Webcast